首页 | 官方网站   微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   315303篇
  免费   17381篇
  国内免费   697篇
农业科学   333381篇
  2020年   2985篇
  2019年   3811篇
  2018年   4566篇
  2017年   5038篇
  2016年   5159篇
  2015年   4513篇
  2014年   5899篇
  2013年   16514篇
  2012年   8277篇
  2011年   10761篇
  2010年   8283篇
  2009年   8737篇
  2008年   10060篇
  2007年   9232篇
  2006年   9456篇
  2005年   8746篇
  2004年   8513篇
  2003年   8267篇
  2002年   7480篇
  2001年   8418篇
  2000年   8113篇
  1999年   7075篇
  1998年   4399篇
  1997年   4429篇
  1996年   4138篇
  1995年   4830篇
  1994年   4197篇
  1993年   3932篇
  1992年   5670篇
  1991年   5829篇
  1990年   5549篇
  1989年   5602篇
  1988年   4979篇
  1987年   5057篇
  1986年   5146篇
  1985年   5234篇
  1984年   4634篇
  1983年   4268篇
  1982年   3332篇
  1981年   3181篇
  1980年   3125篇
  1979年   4113篇
  1978年   3540篇
  1977年   3210篇
  1976年   3082篇
  1975年   3077篇
  1974年   3396篇
  1973年   3394篇
  1972年   3075篇
  1971年   2993篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
L. LANIER 《EPPO Bulletin》1986,16(2):255-263
Les eucalyptus constituent—au moins au meme titre que les genres Pinus et Populus—l'un des genres d'arbres forestiers les plus importants à l'échelle mondiale, et en particulier par l'extension considérable des reboisements (plus de 4 millions d'ha) en régions tropicales, sahéliennes et tempérées chaudes. L'article tente de faire le point sur les problèmes posés par les maladies pouvant gener cet effort de reboisement, notamment en région méditerranéenne, et souligne l'importance et l'avenir des eucalyptus dans cette région. Il est procédéà un inventaire général, à l'échelle mondiale, des maladies des eucalyptus et de l'importance des parasites en cause. Un certain nombre d'entre eux sont étudiés plus en détail, selon qu'ils sont présents dans le pays d'origine des eucalyptus ou dans les zones où ils ont été introduits. Une section est réservée à la région méditerranéenne, où certaines maladies s'en prenant aux racines, aux rameaux, aux feuilles ou au bois ont été identifiées; pour l'instant, la plupart d'entre elles ne sont pas trop graves. Enfin, des propositions et des règles de protection phytosanitaire, visant à restreindre les risques d'introduction des parasites les plus dangereux ou d'extension de ceux existant actuellement, sont citées, en insistant sur les risques de transport de maladies d'une région à une autre par l'intermédiaire des échanges de matériel végétal autres que les graines.  相似文献   
92.
Legumes contain a range of non‐nutritional phytochemicals that may have health‐promoting effects in humans. In this study, we determined the concentrations of four phytoestrogens (coumestrol, apigenin, luteolin and quercetin) in field‐grown alfalfa (Medicago sativa L.). Differences between plants of different stages of maturity, between plant parts, and different canopy segments were assessed. The concentration of individual phytoestrogen in whole herbage varied between 15 and 225 μg g?1 dry matter (DM) and was strongly affected by stage of maturity. Coumestrol and apigenin concentrations were highest at early vegetative stages, luteolin and quercetin at early vegetative and late flowering stages. All phytoestrogens were found in lowest concentrations at the early flowering stage (average 68 μg g?1 DM); stage at which alfalfa is usually harvested when used as a forage source for animals. At vegetative stages, apigenin was the predominant phytoestrogen in herbage followed by coumestrol, the reverse being observed upon initiation of flowering; luteolin and quercetin were found at all stages in similarly lower concentrations. Concentrations of luteolin, quercetin and apigenin were 225, 410 and 690 % greater, respectively, in flowers than in leaves or stems; coumestrol concentration was similar between plant parts. In flowers and stems the predominant phytoestrogens were apigenin and quercetin, followed by coumestrol and luteolin. Similar concentrations (average 26 μg g?1 DM) of each of the four phytoestrogens were found in leaves. Concentrations through the herbage canopy varied and were greatest at >60 cm from the soil surface for apigenin and coumestrol, but greatest at >60 and 0–20 cm for quercetin and at 0–20 cm for luteolin. The results suggest that if alfalfa is to be used as a source of phytoestrogens and is harvested for the production of herbal supplements or nutraceuticals, management will need to be adapted.  相似文献   
93.
腐蚀管道剩余寿命的性能衰减模型研究   总被引:4,自引:0,他引:4  
管道在长期的运行过程中,由于介质和土壤的腐蚀性,管材的微塑性变形、结构转变和渗氢等。不仅会使管道出现各种腐蚀损伤,而且还存在着老化效应和氢化作用,导致管材的脆变并改变材料的塑性,使机械性质参数发生衰退,从管材性能衰减和腐蚀损伤角度研究了管道的剩余寿命,提出了根据结构承载能力的极限值确定塑性变形时工作寿命的方法,为了确定剩余使用寿命,对剪切损伤率和屈服性能比等概念进行定义,在掌握管材金属剪切损害率和屈服性能比的时间特性基础上,建立了剩余寿命计算模型。并给出了算例。  相似文献   
94.
An 11-year-old spayed female Labrador Retriever and a 9-year-old castrated male miniature Poodle were evaluated because of clinical signs of hyperadrenocorticism. Cortisol testing did not support a diagnosis of hypercortisolemia in either dog; however, imaging studies revealed unilateral adrenal tumors in both dogs. Serum concentrations of 17-hydroxyprogesterone, progesterone, and estradiol were high in both dogs, and androstenedione concentrations were also high in 1 dog. It is suspected that sex hormone secretion by the adrenal tumors in these dogs resulted in clinical signs of hyperadrenocorticism. Clinical signs and hormonal abnormalities resolved in the male dog after surgical resection of the tumor. There was no improvement in clinical signs after treatment with mitotane in the female dog, which died 2 months after diagnosis. Histologic evaluation confirmed the presence of adrenocortical carcinoma in both dogs.  相似文献   
95.
96.
97.
An experiment was designed to evaluate the effects of estradiol‐17β (E17β) on follicular wave dynamics and ovulatory response in Holstein heifers receiving either a progestogen ear‐implant (Crestar®; Intervet International b.v. Boxmeer, The Netherlands) or an intravaginal progesterone‐releasing device [controlled internal drug release‐bovine device (Eazibreed, CIDR‐B®; Bodinco BV, Alkmaar, The Netherlands)]. For comparison, another group of heifers was also synchronized using Crestar plus an injection of estradiol valerate (EV) and norgestomet as recommended by the pharmaceutical company. Twenty 20–22‐month‐old cycling Holstein heifers were allocated to one of the following treatment groups at random stages of the oestrous cycle: (I) simultaneous insertion of Crestar and intramuscular injection of 3 mg norgestomet and 5 mg EV (Crestar 9 + EV 9); (II) simultaneous insertion of Crestar and intramuscular injection of 5 mg E17β (Crestar 9 + E17β 9); (III) insertion of Crestar followed 2 days later by intramuscular injection of 5 mg E17β (Crestar 9 + E17β 7); or (IV) insertion of CIDR‐B device followed 2 days later by intramuscular injection of 5 mg E17β (CIDR 9 + E17β 7). The CIDR‐B or Crestar implants were removed after 9 days and all heifers received 500 μg Cloprostenol (Estrumate®, Pitman‐Moore Nederland BV, Houten, The Netherlands). Ovarian ultrasonographic examinations were performed once daily during the synchronization period using a B‐mode scanner equipped with a 7.5 MHz linear‐array transrectal transducer. In addition, heifers were scanned every 12 h after implant/device withdrawal until 3 days after ovulation in order to monitor follicular activity, detect ovulation and subsequent early luteal formation. Detection of oestrus was performed every 6 h for 4 days after device/implant removal. Oestrus was observed 24–32 h before ovulation in all heifers. The mean hours interval from treatment withdrawal to ovulation was not significantly different (84.0 ± 16.5, 77.6 ± 4.1, 73.6 ± 4.1 and 64.0 ± 4.4 h for treatments I, II, III and IV, respectively; p > 0.1). However, the variance for heifers treated with EV + norgestomet was significantly larger (Levene’s Test; p < 0.01) than those treated with E17β. All E17β treatments resulted in dominant follicle suppression and a new wave emerged 4.1 days after treatment compared with 6.6 days for the EV + norgestomet treatment (p < 0.05). The time from emergence of the new ovulatory wave to ovulation was longer for the new wave that emerged after E17β treatment (9.2 ± 0.3 days) than after EV + norgestomet treatment (6.9 ± 0.4 days; p < 0.05). The results of this study suggest that the four treatments used were effective in inducing synchronous behavioural oestrus and ovulation. However, a higher degree of oestrus and ovulation synchrony was observed in heifers treated with E17β than in heifers treated with EV + norgestomet. Synchronization treatments with exogenous E17β or EV + norgestomet at the time of progestin device insertion (Crestar or CIDR‐B) or 2 days later in heifers can regulate a different emergence pattern of ovarian follicular development in randomly cyclic heifers. The E17β was effective in inducing follicular suppression and resulted in the consistent emergence of a new follicular wave.  相似文献   
98.
Grain yield and yield components (grains per ear, grain weight, 1000-grain weight, ear weight, ear seed ratio and dry matter partitioning between ear and seed) were examined in a wheat genotype (PBW-343) with well-filled grains and a Triticale genotype (DT-46) with poorly filled grains (showing grain shrivelling) grown in pots. Six days after anthesis (DAA), benzyladenine (BA) @2 µg ear−1 and abscisic acid (ABA) @4 µg ear−1 were injected at the base of the mother shoot ear in both species. It was observed that, in both wheat and Triticale , BA increased the grain weight, grain number and partitioning of dry matter between ear and seed, whereas ABA decreased the grain weight, grain number and dry matter partitioning between ear and seed. However, these decreases were slower in Triticale than in wheat. BA treatment increased the grain dry matter accumulation, which in turn resulted in better filling of grains and increased the grain weight in both wheat and Triticale . The average grain weight of Triticale was lower than that of wheat. Thus, it appears that variation in grain weight between wheat and Triticale might be due to different availabilities of growth-promoting phytohormones such as cytokinins and assimilates.  相似文献   
99.
100.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号